Joseph A. Dearani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joseph A. Dearani has a total of 993 co-authors. Here are the top co-authors by number of shared publications:
- Hartzell Vernon Schaff
Mayo Clinic
37 shared publications Elizabeth H. Stephens
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
31 shared publicationsHartzell V. Schaff
Department of Surgery, Columbia University, New York, NY
16 shared publications- Elizabeth H. Stephens
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn
15 shared publications - Richard C. Daly
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
13 shared publications Sameh M. Said
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
12 shared publications
Latest Publications
- 7 November 2026
- Published by Elsevier in The Annals of Thoracic Surgery
Survival Is Not Necessarily Success: The Fontan Paradox
- 7 November 2026
- Published by Elsevier in The Annals of Thoracic Surgery
Survival Is Not Necessarily Success: The Fontan Paradox
- 23 October 2026
- Published by Elsevier in The Annals of Thoracic Surgery
Regionalization and Joint Reporting: A Counterpoint Perspective
- 23 October 2026
- Published by Elsevier in The Annals of Thoracic Surgery
Regionalization and Joint Reporting: A Counterpoint Perspective
- 15 October 2026
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
The Congenital Heart Surgeons’ Society Center for Research and Quality 2025 Annual Report
The Congenital Heart Surgeons’ Society (CHSS) is viewed by many as one of the most prestigious professional societies dedicated to pediatric and congenital cardiac surgery. The CHSS Center for Research and Quality (CRQ) Fall 2025 Work Weekend was held in Chicago on Saturday, October 25, 2025. The purpose of this article is to summarize the proceedings of the CHSS CRQ Fall 2025 Work Weekend and to provide a 2025 Annual Report of the CHSS CRQ. At the CHSS CRQ Fall 2025 Work Weekend, multiple topics were discussed related to ongoing CHSS research and quality initiatives. The CHSS CRQ is evolving to keep pace with the rapid evolution of medical informatics and the ever-evolving regulatory issues of clinical research. This 2025 Annual Report of the CHSS CRQ summarizes some of the ongoing initiatives at CHSS CRQ designed to assure that the CHSS CRQ continues to lead innovative and collaborative clinical research to improve pediatric and congenital cardiac care.
- 15 October 2026
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
The Congenital Heart Surgeons’ Society Center for Research and Quality 2025 Annual Report
The Congenital Heart Surgeons’ Society (CHSS) is viewed by many as one of the most prestigious professional societies dedicated to pediatric and congenital cardiac surgery. The CHSS Center for Research and Quality (CRQ) Fall 2025 Work Weekend was held in Chicago on Saturday, October 25, 2025. The purpose of this article is to summarize the proceedings of the CHSS CRQ Fall 2025 Work Weekend and to provide a 2025 Annual Report of the CHSS CRQ. At the CHSS CRQ Fall 2025 Work Weekend, multiple topics were discussed related to ongoing CHSS research and quality initiatives. The CHSS CRQ is evolving to keep pace with the rapid evolution of medical informatics and the ever-evolving regulatory issues of clinical research. This 2025 Annual Report of the CHSS CRQ summarizes some of the ongoing initiatives at CHSS CRQ designed to assure that the CHSS CRQ continues to lead innovative and collaborative clinical research to improve pediatric and congenital cardiac care.
- 6 October 2026
- Published by Elsevier in The Annals of Thoracic Surgery
Transapical Beating-Heart Septal Myectomy: How We Teach It
- 6 October 2026
- Published by Elsevier in The Annals of Thoracic Surgery
Transapical Beating-Heart Septal Myectomy: How We Teach It
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19)
Prognostic Value of Artificial Intelligence ECG–Derived Diastolic Function in Surgical Aortic Valve Replacement
Background: Diastolic dysfunction is common in patients with aortic stenosis and may influence outcomes following surgical aortic valve replacement. We aimed to examine the association of preoperative artificial intelligence (AI)‐generated diastolic function grades with early and late outcomes following aortic valve replacement and how postoperative progression influence prognosis. Methods: We identified 5503 patients undergoing aortic valve replacement between 2000 and 2023. Diastolic function was assessed using a validated deep‐learning AI model applied to 12‐lead ECGs done preoperatively and on postoperative follow‐up. Diastolic grades were classified by AI into Grades 1 to 3. Longitudinal trend analyses and multivariable regression models were used to assess study end points. Results: Among 5503 patients (mean age 72.4±10.8 years; 39% female), higher AI ECG diastolic grades were associated with greater comorbidity burden, including diabetes, renal disease, and heart failure. AI ECG diastolic Grade 3 was independently associated with higher in‐hospital mortality (odds ratio, 2.5; P =0.007) and other complications. At 5‐year follow‐up, patients with Grade 3 showed the least improvement in diastolic function by both ECG and echocardiography. Grades 2 and 3 diastolic function at baseline were independently associated with increased late mortality (hazard ratio, 1.3 and 2.45, respectively; both P <0.001). Additionally, lack of improvement in AI ECG diastolic grade by 1 year was also independently associated with late mortality. Conclusions: AI ECG–derived diastolic function grades strongly correlates with early complications and long‐term mortality and diastolic progression after aortic valve replacement. AI ECG provides a powerful, noninvasive tool for risk stratification and longitudinal monitoring of patients with aortic stenosis.
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19)
Prognostic Value of Artificial Intelligence ECG–Derived Diastolic Function in Surgical Aortic Valve Replacement
Background: Diastolic dysfunction is common in patients with aortic stenosis and may influence outcomes following surgical aortic valve replacement. We aimed to examine the association of preoperative artificial intelligence (AI)‐generated diastolic function grades with early and late outcomes following aortic valve replacement and how postoperative progression influence prognosis. Methods: We identified 5503 patients undergoing aortic valve replacement between 2000 and 2023. Diastolic function was assessed using a validated deep‐learning AI model applied to 12‐lead ECGs done preoperatively and on postoperative follow‐up. Diastolic grades were classified by AI into Grades 1 to 3. Longitudinal trend analyses and multivariable regression models were used to assess study end points. Results: Among 5503 patients (mean age 72.4±10.8 years; 39% female), higher AI ECG diastolic grades were associated with greater comorbidity burden, including diabetes, renal disease, and heart failure. AI ECG diastolic Grade 3 was independently associated with higher in‐hospital mortality (odds ratio, 2.5; P =0.007) and other complications. At 5‐year follow‐up, patients with Grade 3 showed the least improvement in diastolic function by both ECG and echocardiography. Grades 2 and 3 diastolic function at baseline were independently associated with increased late mortality (hazard ratio, 1.3 and 2.45, respectively; both P <0.001). Additionally, lack of improvement in AI ECG diastolic grade by 1 year was also independently associated with late mortality. Conclusions: AI ECG–derived diastolic function grades strongly correlates with early complications and long‐term mortality and diastolic progression after aortic valve replacement. AI ECG provides a powerful, noninvasive tool for risk stratification and longitudinal monitoring of patients with aortic stenosis.
- 6 September 2026
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 122 (5) , 1288-1289
Two Ventricles: But at What Cost, and in Whose Hands?
- 6 September 2026
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 122 (5) , 1288-1289
Two Ventricles: But at What Cost, and in Whose Hands?
- 13 February 2026
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 121 (4) , 929-930
Reframing the Modified Konno: Bidirectional Exposure Without Right Ventricle Incision
- 13 February 2026
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 121 (4) , 929-930
Reframing the Modified Konno: Bidirectional Exposure Without Right Ventricle Incision
- 30 January 2026
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 121 (4) , 999-1000
Phenotype-Guided Septal Myectomy in Obstructive HCM
- 30 January 2026
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 121 (4) , 999-1000
Phenotype-Guided Septal Myectomy in Obstructive HCM
- 5 December 2025
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 171 (6) , 1275-1278
Caring for VIP patients in cardiothoracic surgery: Navigating bias, pressure, and protocol
- 5 December 2025
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 171 (6) , 1275-1278
Caring for VIP patients in cardiothoracic surgery: Navigating bias, pressure, and protocol
- 1 December 2025
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (12) , e012990
Long-Term Outcomes After Fontan Conversion Operation: A Comparative Analysis Based on Type of Fontan Connection
BACKGROUND: Fontan conversion (FC) is associated with a lower risk of atrial arrhythmias and thromboembolism, but it is unknown whether FC improves long-term survival. The purpose of this study was to assess the impact of FC on transplant-free survival. METHOD: Adults with Fontan palliation were divided into 3 groups: (1) atriopulmonary Fontan connection; (2) atriopulmonary Fontan and subsequent FC to total cavopulmonary connection (TCPC); (3) TCPC at initial Fontan operation. The risk of death/transplant was compared between the 3 groups using Cox regression analysis. RESULTS: We studied 534 patients (age 27±9 years; males [N=298; 56%]). Patients were divided into atriopulmonary Fontan group (N=199, 37%); FC-TCPC (N=138, 26%); and TCPC (N=197, 37%). The FC-TCPC and TCPC groups have similar 15-year incidence of death/transplant (42% versus 47%; P =0.8), even after excluding the 8% operative mortality in the FC-TCPC group (38% versus 47%; P =0.3). On multivariable analyses, neither FC nor the type of Fontan connection was associated with death/transplant. Rather, the risk factors for death/transplant were older age, hepatorenal dysfunction, heart failure, and higher Fontan pressures. The prevalence and severity of these comorbidities increased with age, suggesting that these factors reflect the duration of Fontan physiology, rather than the type of Fontan connection. CONCLUSIONS: These findings, in addition to the high operative mortality associated with FC, suggest that this may not be the optimal treatment option for most adults with atriopulmonary Fontan presenting with Fontan failure. Duration of Fontan physiology rather than the type of Fontan connection may be the main determinant of outcomes.
- 1 December 2025
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (12) , e012990
Long-Term Outcomes After Fontan Conversion Operation: A Comparative Analysis Based on Type of Fontan Connection
BACKGROUND: Fontan conversion (FC) is associated with a lower risk of atrial arrhythmias and thromboembolism, but it is unknown whether FC improves long-term survival. The purpose of this study was to assess the impact of FC on transplant-free survival. METHOD: Adults with Fontan palliation were divided into 3 groups: (1) atriopulmonary Fontan connection; (2) atriopulmonary Fontan and subsequent FC to total cavopulmonary connection (TCPC); (3) TCPC at initial Fontan operation. The risk of death/transplant was compared between the 3 groups using Cox regression analysis. RESULTS: We studied 534 patients (age 27±9 years; males [N=298; 56%]). Patients were divided into atriopulmonary Fontan group (N=199, 37%); FC-TCPC (N=138, 26%); and TCPC (N=197, 37%). The FC-TCPC and TCPC groups have similar 15-year incidence of death/transplant (42% versus 47%; P =0.8), even after excluding the 8% operative mortality in the FC-TCPC group (38% versus 47%; P =0.3). On multivariable analyses, neither FC nor the type of Fontan connection was associated with death/transplant. Rather, the risk factors for death/transplant were older age, hepatorenal dysfunction, heart failure, and higher Fontan pressures. The prevalence and severity of these comorbidities increased with age, suggesting that these factors reflect the duration of Fontan physiology, rather than the type of Fontan connection. CONCLUSIONS: These findings, in addition to the high operative mortality associated with FC, suggest that this may not be the optimal treatment option for most adults with atriopulmonary Fontan presenting with Fontan failure. Duration of Fontan physiology rather than the type of Fontan connection may be the main determinant of outcomes.